Rating strategy

Novo Nordisk considers the maintenance of two investment grade ratings an important target; the present rating and outlook from Moody's and Standard & Poor's are shown below.

AgencyRatingOutlook
S&PAStable
Moody'sA2Stable

 

Novo Nordisk’s goal is to ensure that rating agencies continue to be comfortable with Novo Nordisk’s strategy and performance. The company's strategy is to maintain liquidity well in line with the comfort level of the agencies. Annual review meetings are arranged with the Novo Nordisk management, and Novo Nordisk keep in regular contact with the rating analysts.

See also

 

  •  
  •  
  •  
Changing Diabetes Bus Tour
  •